Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group

    Active surveillance (AS) and adjuvant chemotherapy (AC) with carboplatin are valid alternatives for managing stage I seminoma, and most relapses can be cured with cisplatin-based chemotherapy. However, some re...

    J. Aparicio, X. García del Muro, P. Maroto in Clinical and Translational Oncology (2021)

  2. Article

    Open Access

    Correction to: Recommendations for follow‑up of colorectal cancer survivors

    In the published article, the following information was missing:

    R. Vera, J. Aparicio, F. Carballo, M. Esteva in Clinical and Translational Oncology (2019)

  3. Article

    Open Access

    Recommendations for follow-up of colorectal cancer survivors

    Colorectal cancer (CRC) is one of the tumours with the highest incidence and mortality in the Spanish population. Nevertheless, the advances in prevention and treatment have contributed to an increased number ...

    R. Vera, J. Aparicio, F. Carballo, M. Esteva in Clinical and Translational Oncology (2019)

  4. No Access

    Article

    Controversies in the management of stage I seminoma: adjuvant carboplatin revisited

    J. Aparicio, J. Terrasa in Clinical and Translational Oncology (2019)

  5. Article

    Open Access

    SEOM clinical guidelines to primary prevention of cancer (2018)

    Cancer is the leading social and healthcare problem of the twenty-first century. The aim of primary prevention is to decrease the incidence of cancer by avoiding the known causes and risk factors. Nevertheless...

    J. Bayo, R. Molina, J. Pérez, E. Pérez-Ruíz in Clinical and Translational Oncology (2019)

  6. Article

    Open Access

    SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer (2018)

    Colorectal cancer (CRC) is the second cause of cancer death in Spain, the objective of this guide published by the Spanish Society of Medical Oncology is to develop a consensus for the diagnosis and management...

    M. A. Gómez-España, J. Gallego, E. González-Flores in Clinical and Translational Oncology (2019)

  7. No Access

    Article

    Prognostic factors for relapse in stage I testicular seminoma: tumor size and rete testis invasion revisited

    J. Aparicio in Clinical and Translational Oncology (2018)

  8. No Access

    Article

    An internally validated new clinical and inflammation-based prognostic score for patients with advanced hepatocellular carcinoma treated with sorafenib

    Sorafenib is a standard treatment for patients (pts) with advanced hepatocellular carcinoma (aHCC), although the clinical benefit is heterogeneous between different pts groups. Among novel prognostic factors, ...

    R. Diaz-Beveridge, G. Bruixola, D. Lorente in Clinical and Translational Oncology (2018)

  9. Article

    Open Access

    SEOM clinical guidelines in gestational trophoblastic disease (2017)

    Gestational trophoblastic disease (GTD) is a rare but curable disease. Recent improvements in diagnosis and molecular biology have resulted in changes in staging and treatment. These guidelines provide evidenc...

    A. Santaballa, Y. García, A. Herrero, N. Laínez in Clinical and Translational Oncology (2018)

  10. No Access

    Chapter

    A Successful Early Warning System for Hydroclimatic Extreme Events: The Case of La Paz City Mega Landslide

    Despite the development of adaptation initiatives that are showing to be effective the existent climate change and variability public adaptation policies and strategies are still insufficient due to the severi...

    M. Aparicio-Effen, I. Arana-Pardo in Climate Change Adaptation in Latin America (2018)

  11. Article

    Open Access

    Erratum to: Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies

    R. Vera, A. Ferrández, C. J. Ferrer, C. Flores in Clinical and Translational Oncology (2017)

  12. Article

    Open Access

    Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies

    Pancreatic cancer (PC) is a disease with bad prognosis. It is usually diagnosed at advanced stages and its treatment is complex. The aim of this consensus document was to provide recommendations by experts tha...

    R. Vera, A. Ferrández, C. J. Ferrer, C. Flores in Clinical and Translational Oncology (2017)

  13. Article

    Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions

    J. Salvador, J. Aparicio, F. J. Baron in Clinical and Translational Oncology (2017)

  14. Article

    Open Access

    SEOM clinical guidelines for the management of germ cell testicular cancer (2016)

    Testicular cancer represents the most common malignancy in males aged 15–34 years and is considered a model of curable neoplasm. Maintaining success, reducing treatment burden, and focusing on survivorship are...

    J. Aparicio, J. Terrasa, I. Durán, J. R. Germà-Lluch in Clinical and Translational Oncology (2016)

  15. Article

    Open Access

    SEOM Clinical Guideline of localized rectal cancer (2016)

    Localized rectal adenocarcinoma is a heterogeneous disease and current treatment recommendations are based on a preoperative multidisciplinary evaluation. High-resolution magnetic resonance imaging and endosco...

    E. González-Flores, F. Losa, C. Pericay, E. Polo in Clinical and Translational Oncology (2016)

  16. No Access

    Chapter

    Introducing Hydro-Climatic Extremes and Human Impacts in Bolivia, Paraguay and Uruguay

    Climate change and ENSO events are increasing hydro-climatic risks and health impacts in Bolivia, Paraguay and Uruguay, as well as social inequalities in Bolivia and Paraguay. Climate scenarios project increas...

    M. Aparicio-Effen, I. Arana, J. Aparicio, Pamela Cortez in Climate Change and Health (2016)

  17. Article

    Open Access

    SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015

    Colorectal cancer (CRC) is the second leading cause of cancer dead in Spain. About half the patients will eventually develop distant metastases. However, as treatment options are expanding, prognosis has stead...

    E. Aranda, J. Aparicio, V. Alonso, X. Garcia-Albeniz in Clinical and Translational Oncology (2015)

  18. No Access

    Article

    Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base

    Brain metastases of testicular germ cell tumor (TGCT) are a rare event. Prognostic is poor and there is not much evidence on optimal management of these patients.

    R. Girones, J. Aparicio, P. Roure, J. R. Germa-Lluch in Clinical and Translational Oncology (2014)

  19. Article

    Open Access

    First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

    Subgroup analyses of clinical studies suggest that bevacizumab plus XELOX is effective and tolerable in elderly patients with metastatic colorectal cancer (mCRC). The prospective BECOX study examined the effic...

    J Feliu, A Salud, M J Safont, C García-Girón, J Aparicio in British Journal of Cancer (2014)

  20. No Access

    Article

    Positron emission tomography (PET) is not indicated in the postchemotherapy evaluation of advanced non-seminomatous testicular germ cell tumors

    J. Aparicio in Clinical and Translational Oncology (2014)

previous disabled Page of 2